The cryostat market has seen considerable growth due to a variety of factors.
• In the past few years, a significant growth has been observed in the cryostat market size. The market which was valued at $2.56 billion in 2024, is projected to grow to $2.7 billion in 2025, marking a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the historic period include advancements in biomedical research, increased use of cryo-electron microscopy (cryo-EM), development of biobanking and biorepositories, progress in cancer research and diagnostics, enhancements in drug discovery and development, advancements in tissue engineering, and the rise in cryonics services.
The Cryostat market is expected to maintain its strong growth trajectory in upcoming years.
• It is anticipated that the cryostat market will experience significant expansion in the upcoming years, with projections suggesting it will reach a value of $3.66 billion by 2029, increasing at a compound annual growth rate (CAGR) of 7.9%.
The predicted growth during this period can be linked to its increasing use in pharmaceutical manufacture, the growing significance of genomic studies, the worldwide growth of biobanking activities, the maintenance of quality in pharmaceuticals, the move towards point-of-care diagnostics and developments in cryogenic storage systems. Key trends expected within this period include advancements in cryogenic technologies, breakthroughs in imaging technology, the incorporation of artificial intelligence, partnership for research and innovation, and utilization in nanotechnology.
The escalating occurrence of neuromuscular diseases is set to drive the growth of the cryostat market. These diseases typically involve dysfunction or harm to the peripheral nervous system. The predominant issue amongst these disorders is progressive muscle weakness. A cryostat serves as a swift diagnostic tool for various disorders and diseases, including neuromuscular ones. Therefore, as neuromuscular diseases increase, so does the demand for the cryostat market. To illustrate, Osteopaths For Industry Ltd., a UK-based company offering injury prevention training and consulting services for musculoskeletal conditions, noted 477,000 cases of work-related musculoskeletal disorders in 2021–2022. Similarly, the World Health Organization, a US-based international organization, reported that around 1.71 billion individuals were suffering from musculoskeletal disorders in July 2022. Thus, the growing incidence of neuromuscular diseases is propelling the expansion of the cryostat market.
The cryostat market covered in this report is segmented –
1) By Type: Closed-Cycle Cryostats, Continuous-Flow Cryostats, Bath Cryostats, Multistage Cryostats
2) By System Component: Dewars, Transfer Tubes, Gas Flow Pumps, Temperature Controllers, High Vacuum Pumps, Microtone Bladed
3) By Cryogen: Helium, Nitrogen
4) By End-Use Industry: Healthcare, Energy And Power, Aerospace, Metallurgy, Biotechnology, Forensic Science, Marine Biology
Subsegments:
1) By Closed-Cycle Cryostats: Helium Closed-Cycle Cryostats, Nitrogen Closed-Cycle Cryostats
2) By Continuous-Flow Cryostats: Flowing Helium Cryostats, Flowing Nitrogen Cryostats
3) By Bath Cryostats: Liquid Helium Bath Cryostats, Liquid Nitrogen Bath Cryostats
4) By Multistage Cryostats: Two-Stage Cryostats, Three-Stage Cryostats
Leading companies in the cryostat market are promoting sustainability and reducing operational costs by developing innovative products like helium recovery solutions, which increase the efficiency of cryogenic systems. This type of solution is intended to capture, recycle and reuse helium—a precious, finite resource typically used in cryostat-related applications. To illustrate, in April 2024, Bluefors, a cryogenic measurement systems manufacturer from the UK, introduced Cryomech HeRL02-RM. This innovative helium recovery device is specifically tailored for single Nuclear Magnetic Resonance (NMR) systems. The HeRL02-RM creates a closed-loop system that gathers evaporated helium from NMR magnets, which is then channeled through a vapor return line towards a liquefier powered by Pulse Tube Cryocooler. Subsequently, the helium is instantly liquefied and redirected back to the magnet's helium bath.
Major companies operating in the cryostat market include:
• Lake Shore Cryotronics Inc
• Cryomech Inc
• Epredia
• Hacker Instruments & Industries Inc
• Histo-Line Laboratories Srl
• Jinhua YIDI Medical Appliance Co Ltd
• SLEE Medical GmbH
• Leica Biosystems
• Lupetec Technologies
• MEDITE Medical GmbH
• Boeckeler Instruments Inc
• Bright Instruments Ltd
• Precision Cryogenics Systems Inc
• Atico Medical Pvt Ltd
• Biobase Biodusty Co Ltd
• Cryofab Inc.
• Amos Scientific
• Thermo Fisher Scientific Inc.
• Oxford Instruments
• Star Cryoelectronics
• Infrared laboratories
• Attocube Systems
• Montana Instruments
• Quantum Design
• ICE Oxford
• Cryogenic Limited
• Bluefors
• Cryoquip
• CryoMAgnetics
• Vacree Technologies
North America was the largest region in the cryostat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cryostat market during the forecast period. The regions covered in the cryostat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa